{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:33:41Z","timestamp":1773945221433,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372236"],"award-info":[{"award-number":["81372236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Postdoctoral Science Foundation","award":["12R21411-500"],"award-info":[{"award-number":["12R21411-500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>The aim of this study was to explore risk factors for the prognosis of lung cancer with simple brain metastasis (LCSBM) patients and to establish a prognostic predictive nomogram for LCSBM patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Three thousand eight hundred and six cases of LCSBM\u00a0were extracted from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2015 using SEER Stat 8.3.5. Lung cancer patients only had brain metastasis with no other organ metastasis were defined as LCSBM patients. Prognostic factors of LCSBM were analyzed with log-rank method and Cox proportional hazards model. Independent risk and  protective prognostic factors were used to construct nomogram with accelerated failure time model. C-index was used to evaluate the prediction effect of nomogram.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results and conclusion<\/jats:title>\n                <jats:p>The younger patients (18\u201365\u00a0years old) accounted for 54.41%, while patients aged over 65 accounted for 45.59%.The ratio of male: female was 1:1. Lung cancer in the main bronchus, upper lobe, middle lobe and lower lobe were accounted for 4.91%, 62.80%, 4.47% and 27.82% respectively; and adenocarcinoma accounted for 57.83% of all lung cancer types. The overall median survival time was 12.2\u00a0months. Survival rates for 1-, 3- and 5-years were 28.2%, 8.7% and 4.7% respectively. We found female (HR\u2009=\u20090.81, 95% CI 0.75\u20130.87), the married (HR\u2009=\u20090.80; 95% CI 0.75\u20130.86), the White (HR\u2009=\u20090.90, 95% CI 0.84\u20130.95) and primary site (HR\u2009=\u20090.45, 95% CI 0.39\u20130.52) were independent protective factors while higher age (HR\u2009=\u20091.51, 95% CI 1.40\u20131.62), advanced grade (HR\u2009=\u20091.19, 95% CI 1.12\u20131.25) and advanced T stage (HR\u2009=\u20091.09, 95% CI 1.05\u20131.13) were independent risk prognostic factors affecting the survival of LCSBM patients. We constructed the nomogram with above independent factors, and the C-index value was 0.634 (95% CI 0.622\u20130.646). We developed a nomogram with seven significant LCSBM independent prognostic factors to provide prognosis prediction.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-01936-w","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T16:03:19Z","timestamp":1651075399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prognosis of lung cancer with simple brain metastasis patients and establishment of survival prediction models: a study based on real events"],"prefix":"10.1186","volume":"22","author":[{"given":"Jiaying","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixiu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shicheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengxi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"9","key":"1936_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12032-018-1182-8","volume":"35","author":"AJW Gibson","year":"2018","unstructured":"Gibson AJW, Li H, D\u2019Silva A, Tudor RA, Elegbede AA, Otsuka SM, et al. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer. Med Oncol. 2018;35(9):117. https:\/\/doi.org\/10.1007\/s12032-018-1182-8.","journal-title":"Med Oncol"},{"issue":"4","key":"1936_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nec.2020.06.001","volume":"31","author":"P Sacks","year":"2020","unstructured":"Sacks P, Rahman M. Epidemiology of brain metastases. Neurosurg Clin N Am. 2020;31(4):481\u20138. https:\/\/doi.org\/10.1016\/j.nec.2020.06.001.","journal-title":"Neurosurg Clin N Am"},{"issue":"1","key":"1936_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cllc.2011.05.007","volume":"13","author":"W Ortuzar","year":"2012","unstructured":"Ortuzar W, Hanna N, Pennella E, Peng G, Langer C, Monberg M, Scagliotti G. Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer. Clin Lung Cancer. 2012;13(1):24\u201330. https:\/\/doi.org\/10.1016\/j.cllc.2011.05.007.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"1936_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3779\/j.issn.1009-3419.2018.03.15","volume":"21","author":"L Dai","year":"2018","unstructured":"Dai L, Yan W, Kang X, Fu H, Yang Y, Zhou H, et al. Exploration of postoperative follow-up strategies for early staged NSCLC patients on the basis of follow-up result of 416 stage I NSCLC patients after lobectomy. Zhongguo Fei Ai Za Zhi. 2018;21(3):199\u2013203. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2018.03.15 (Chinese).","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"3\u20134","key":"1936_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2152\/jmi.61.241","volume":"61","author":"M Hanibuchi","year":"2014","unstructured":"Hanibuchi M, Kim SJ, Fidler IJ, Nishioka Y. The molecular biology of lung cancer brain metastasis: an overview of current comprehensions and future perspectives. J Med Invest. 2014;61(3\u20134):241\u201353. https:\/\/doi.org\/10.2152\/jmi.61.241.","journal-title":"J Med Invest"},{"issue":"4","key":"1936_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ijrobp.2015.02.048","volume":"92","author":"C Oberije","year":"2015","unstructured":"Oberije C, De Ruysscher D, Houben R, van de Heuvel M, Uyterlinde W, Deasy JO, et al. A validated prediction model for overall survival from stage III non-small cell lung cancer: toward survival prediction for individual patients. Int J Radiat Oncol Biol Phys. 2015;92(4):935\u201344. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.02.048.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1936_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","volume":"12","author":"MJ Hayat","year":"2007","unstructured":"Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12(1):20\u201337. https:\/\/doi.org\/10.1634\/theoncologist.12-1-20.","journal-title":"Oncologist"},{"issue":"9","key":"1936_CR8","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243\u201360. https:\/\/doi.org\/10.1097\/JTO.0000000000000630.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"1936_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00292-010-1349-3","volume":"31","author":"C Wittekind","year":"2010","unstructured":"Wittekind C. TNM-System 2010\u202f: Zur 7. Auflage der TNM-Klassifikation maligner Tumoren [2010 TNM system: on the 7th edition of TNM classification of malignant tumors]. Pathologe. 2010;31(5):331\u20132. https:\/\/doi.org\/10.1007\/s00292-010-1349-3 (German).","journal-title":"Pathologe."},{"issue":"16","key":"1936_CR10","doi-asserted-by":"publisher","first-page":"27047","DOI":"10.18632\/oncotarget.15968","volume":"8","author":"I Daugaard","year":"2017","unstructured":"Daugaard I, Ven\u00f8 MT, Yan Y, Kjeldsen TE, Lamy P, Hager H, et al. Small RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinoma. Oncotarget. 2017;8(16):27047\u201361. https:\/\/doi.org\/10.18632\/oncotarget.15968.","journal-title":"Oncotarget"},{"issue":"4","key":"1936_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.asjsur.2015.03.003","volume":"38","author":"L Chow","year":"2015","unstructured":"Chow L, Suen D, Ma KK, Kwong A. Identifying risk factors for brain metastasis in breast cancer patients: implication for a vigorous surveillance program. Asian J Surg. 2015;38(4):220\u20133. https:\/\/doi.org\/10.1016\/j.asjsur.2015.03.003.","journal-title":"Asian J Surg"},{"issue":"1","key":"1936_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00066-013-0439-6","volume":"190","author":"L Gerdan","year":"2014","unstructured":"Gerdan L, Segedin B, Nagy V, Khoa MT, Trang NT, Schild SE, et al. Brain metastasis from non-small cell lung cancer (NSCLC): prognostic importance of the number of involved extracranial organs. Strahlenther Onkol. 2014;190(1):64\u20137. https:\/\/doi.org\/10.1007\/s00066-013-0439-6.","journal-title":"Strahlenther Onkol"},{"issue":"12","key":"1936_CR13","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00066-013-0442-y","volume":"189","author":"D Rades","year":"2013","unstructured":"Rades D, Gerdan L, Segedin B, Nagy V, Khoa MT, Trang NT, et al. Brain metastasis: prognostic value of the number of involved extracranial organs. Strahlenther Onkol. 2013;189(12):996\u20131000. https:\/\/doi.org\/10.1007\/s00066-013-0442-y.","journal-title":"Strahlenther Onkol"},{"key":"1936_CR14","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.2147\/CMAR.S183878","volume":"10","author":"J Deng","year":"2018","unstructured":"Deng J, Ren Z, Wen J, Wang B, Hou X, Xue Z, et al. Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer. Cancer Manag Res. 2018;10:6143\u201356. https:\/\/doi.org\/10.2147\/CMAR.S183878.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"1936_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/jech.50.1.51","volume":"50","author":"A Kvikstad","year":"1996","unstructured":"Kvikstad A, Vatten LJ. Cancer risk and prognosis in Norway: comparing women in their first marriage with women who have never married. J Epidemiol Community Health. 1996;50(1):51\u20135. https:\/\/doi.org\/10.1136\/jech.50.1.51.","journal-title":"J Epidemiol Community Health"},{"key":"1936_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.humpath.2017.03.022","volume":"64","author":"R Li","year":"2017","unstructured":"Li R, Zhang K, Siegal GP, Wei S. Clinicopathological factors associated with survival in patients with breast cancer brain metastasis. Hum Pathol. 2017;64:53\u201360. https:\/\/doi.org\/10.1016\/j.humpath.2017.03.022.","journal-title":"Hum Pathol"},{"issue":"4","key":"1936_CR17","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.prro.2017.01.001","volume":"7","author":"JA Miller","year":"2017","unstructured":"Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Suh JH, Barnett GH, et al. The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases. Pract Radiat Oncol. 2017;7(4):e263\u201373. https:\/\/doi.org\/10.1016\/j.prro.2017.01.001.","journal-title":"Pract Radiat Oncol"},{"issue":"10","key":"1936_CR18","doi-asserted-by":"publisher","first-page":"17229","DOI":"10.18632\/oncotarget.11236","volume":"8","author":"Y She","year":"2017","unstructured":"She Y, Zhao L, Dai C, Ren Y, Zha J, Xie H, et al. Preoperative nomogram for identifying invasive pulmonary adenocarcinoma in patients with pure ground-glass nodule: a multi-institutional study. Oncotarget. 2017;8(10):17229\u201338. https:\/\/doi.org\/10.18632\/oncotarget.11236.","journal-title":"Oncotarget"},{"issue":"4","key":"1936_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/07357907.2018.1466895","volume":"36","author":"O Abdel-Rahman","year":"2018","unstructured":"Abdel-Rahman O. Outcomes of surgery as part of the management of metastatic non-small-cell lung cancer: a surveillance, epidemiology and end results database analysis. Cancer Invest. 2018;36(4):238\u201345. https:\/\/doi.org\/10.1080\/07357907.2018.1466895.","journal-title":"Cancer Invest"},{"issue":"3","key":"1936_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.21873\/invivo.11082","volume":"31","author":"G Karagkiouzis","year":"2017","unstructured":"Karagkiouzis G, Spartalis E, Moris D, Patsouras D, Athanasiou A, Karathanasis I, et al. Surgical management of non-small cell lung cancer with solitary hematogenous metastases. In Vivo. 2017;31(3):451\u20134. https:\/\/doi.org\/10.21873\/invivo.11082.","journal-title":"In Vivo"},{"issue":"35","key":"1936_CR21","doi-asserted-by":"publisher","first-page":"56998","DOI":"10.18632\/oncotarget.10933","volume":"7","author":"G Han","year":"2016","unstructured":"Han G, Bi J, Tan W, Wei X, Wang X, Ying X, et al. A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis? Oncotarget. 2016;7(35):56998\u20137010. https:\/\/doi.org\/10.18632\/oncotarget.10933.","journal-title":"Oncotarget"},{"issue":"3","key":"1936_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.lungcan.2014.10.001","volume":"86","author":"DW Lee","year":"2014","unstructured":"Lee DW, Shin DY, Kim JW, Keam B, Kim TM, Kim HJ, et al. Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: integrating with lung specific GPA score. Lung Cancer. 2014;86(3):363\u20138. https:\/\/doi.org\/10.1016\/j.lungcan.2014.10.001.","journal-title":"Lung Cancer"},{"issue":"6","key":"1936_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1177\/0962280211434179","volume":"24","author":"P Fu","year":"2015","unstructured":"Fu P, Panneerselvam A, Clifford B, Dowlati A, Ma PC, Zeng G, et al. Simpson\u2019s paradox - aggregating and partitioning populations in health disparities of lung cancer patients. Stat Methods Med Res. 2015;24(6):937\u201348. https:\/\/doi.org\/10.1177\/0962280211434179.","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"1936_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3760\/cma.j.issn.0253-3766.2013.03.008","volume":"35","author":"XX Li","year":"2013","unstructured":"Li XX, Jin L, Sun ZF, Gu F, Li WL, Ma YJ. Robo1 expression in non-small cell lung cancer and its brain metastasis. Zhonghua Zhong Liu Za Zhi. 2013;35(3):198\u2013201. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2013.03.008 (Chinese).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"7","key":"1936_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jtho.2016.04.014","volume":"11","author":"H Yu","year":"2016","unstructured":"Yu H, Boyle TA, Zhou C, Rimm DL, Hirsch FR. PD-L1 expression in lung cancer. J Thorac Oncol. 2016;11(7):964\u201375. https:\/\/doi.org\/10.1016\/j.jtho.2016.04.014.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"1936_CR26","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s11427-019-1622-5","volume":"63","author":"Y Yang","year":"2020","unstructured":"Yang Y, Yu Y, Lu S. Effectiveness of PD-1\/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge. Sci China Life Sci. 2020;63(10):1499\u2013514. https:\/\/doi.org\/10.1007\/s11427-019-1622-5.","journal-title":"Sci China Life Sci"},{"issue":"11","key":"1936_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.jtho.2018.07.001","volume":"13","author":"T Patil","year":"2018","unstructured":"Patil T, Smith DE, Bunn PA, Aisner DL, Le AT, Hancock M, et al. The incidence of brain metastases in stage IV ROS1-rearranged non-small cell lung cancer and rate of central nervous system progression on crizotinib. J Thorac Oncol. 2018;13(11):1717\u201326. https:\/\/doi.org\/10.1016\/j.jtho.2018.07.001.","journal-title":"J Thorac Oncol"},{"key":"1936_CR28","doi-asserted-by":"publisher","first-page":"102178","DOI":"10.1016\/j.ctrv.2021.102178","volume":"95","author":"J Remon","year":"2021","unstructured":"Remon J, Pignataro D, Novello S, Passiglia F. Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer. Cancer Treat Rev. 2021;95:102178. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102178.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"1936_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cllc.2013.05.002","volume":"14","author":"J Bauml","year":"2013","unstructured":"Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, et al. Determinants of survival in advanced non\u2013small-cell lung cancer in the era of targeted therapies. Clin Lung Cancer. 2013;14(5):581\u201391. https:\/\/doi.org\/10.1016\/j.cllc.2013.05.002.","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"1936_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.7314\/apjcp.2015.16.2.647","volume":"16","author":"XY Wu","year":"2015","unstructured":"Wu XY, Huang XE. Screening for patients with non-small cell lung cancer who could survive long term chemotherapy. Asian Pac J Cancer Prev. 2015;16(2):647\u201352. https:\/\/doi.org\/10.7314\/apjcp.2015.16.2.647.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"1936_CR31","first-page":"666","volume":"33","author":"Z Li","year":"2011","unstructured":"Li Z, Zhang LJ, Wang WP, Guo K, Shao JY, Rong TH. Correlation between EGFR gene mutation and high copy number and their association with the clinicopathological features in Chinese patients with non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi. 2011;33(9):666\u201370 (Chinese).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"1","key":"1936_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-016-0477-x","volume":"36","author":"J Wu","year":"2017","unstructured":"Wu J, Zhou L, Huang L, Gu J, Li S, Liu B, et al. Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients. J Exp Clin Cancer Res. 2017;36(1):4. https:\/\/doi.org\/10.1186\/s13046-016-0477-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"1936_CR33","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","volume":"33","author":"W Liang","year":"2015","unstructured":"Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015;33(8):861\u20139. https:\/\/doi.org\/10.1200\/JCO.2014.56.6661.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1936_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3978\/j.issn.2304-3865.2015.06.01","volume":"4","author":"VA Venur","year":"2015","unstructured":"Venur VA, Ahluwalia MS. Prognostic scores for brain metastasis patients: use in clinical practice and trial design. Chin Clin Oncol. 2015;4(2):18. https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2015.06.01.","journal-title":"Chin Clin Oncol"},{"issue":"9","key":"1936_CR35","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1245\/s10434-016-5206-3","volume":"23","author":"F Zhang","year":"2016","unstructured":"Zhang F, Zheng W, Ying L, Wu J, Wu S, Ma S, et al. A nomogram to predict brain metastases of resected non-small cell lung cancer patients. Ann Surg Oncol. 2016;23(9):3033\u20139. https:\/\/doi.org\/10.1245\/s10434-016-5206-3.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1936_CR36","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12885-017-3763-x","volume":"17","author":"X Ji","year":"2017","unstructured":"Ji X, Zhuang Y, Yin X, Zhan Q, Zhou X, Liang X. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram. BMC Cancer. 2017;17(1):774. https:\/\/doi.org\/10.1186\/s12885-017-3763-x.","journal-title":"BMC Cancer"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-01936-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T16:05:48Z","timestamp":1651075548000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-01936-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1936"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-01936-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"9 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}